School of Medicine » Psychiatry and Behavioral Sciences » Addictions, Drug & Alcohol Institute

RSS XML iCal Seattle, WAPacific Time
This hCalendar-compliant page is optimized for search engines. View this calendar as published at calendar.washington.edu.

Outreach-Based Long-Acting Injectable Buprenorphine: A Viable Pathway to Closing OUD Treatment Gaps

Overdose deaths involving fentanyl increased by 45% from 2021 to 2022 in Washington State, disproportionately involving people experiencing houselessness, highlighting the urgent need to increase access to medications for opioid use disorder (MOUD) in this population. A multidisciplinary outreach team is successfully breaking down those barriers by offering field-based long-acting injectable buprenorphine (LAI-BUP) to people with opioid use disorder in outreach settings including permanent support housing sites. Field-based LAI-BUP injections offer a significant advantage to this population, providing a reliable and convenient long-acting option that increases sustained therapeutic OUD treatment and ultimately aiding in peoples’ continued success in housing.  Learning objectives: To learn about buprenorphine long-acting injections and their benefits to those with Opioid Use Disorder.  , To understand the importance of advocating for creative solutions to provide better care to the people we serve when more… Event interval: Single day event. Online Meeting Link: https://washington.zoom.us/webinar/register/WN_8J_A_f8DQt-Pb3U--wnhCw. Accessibility Contact: Meg Brunner, meganw@uw.edu. Event Types: Lectures/Seminars. Event sponsors: Northwest ATTC at the UW Addictions, Drug & Alcohol Institute. Wednesday, January 21, 2026, 12:00 PM – 1:00 PM. Webinar - register at: https://washington.zoom.us/webinar/register/WN_8J_A_f8DQt-Pb3U--wnhCw. For more info visit washington.zoom.us.

ADAI Lunch & Learn: Of Mice and Misuse: Preclinical Modeling of Fentanyl Use Disorder

Presenter:  Kevin Coffey, PhD. Research Assistant Professor, UW Psychiatry & Behavioral Sciences Kevin Coffey is a Research Assistant Professor in Psychiatry and Behavioral Sciences at the University of Washington and a MIRECC Investigator at the VA Puget Sound. His lab aims to identify the neural mechanisms underlying substance use disorders and maladaptive decision making. Dr. Coffey’s current focus is on studying the neurobiological consequences and predictors of chronic fentanyl use. To accomplish this, his lab utilizes cutting-edge in-vivo optical neuroscience tools (photometry, optogenetics, MiniScopes, etc.) along with a newly developed oral fentanyl self-administration model for rats and mice. His recently funded ADAI pilot grant aims to explore the use of the GLP-1R agonist dulaglutide for treatment of fentanyl use disorder in his rodent models. Event interval: Single day event. Online Meeting Link: https://washington.zoom.us/meeting/register/R2E_CapZRbybpRYqz3fewA#/registration. Accessibility Contact: Meg Brunner, meganw@uw.edu. Event Types: Lectures/Seminars. Event sponsors: UW Addictions, Drug & Alcohol Institute (ADAI). Thursday, January 29, 2026, 12:00 PM – 1:00 PM. Webinar - register at: https://washington.zoom.us/meeting/register/R2E_CapZRbybpRYqz3fewA#/registration. For more info visit washington.zoom.us.

What's the Latest? Opioid Recovery & Care Access (ORCA): A Closer Look

Building on January's What’s the Latest? session (find the recording here), this webinar dives deeper into DESC’s ORCA Center—a 24/7, judgment-free space for recovery after overdose and initiation of medications for opioid use disorder (MOUD). You’ll learn about the care ORCA provides, its person-centered approach, and how the team works together to deliver timely, compassionate support to the community. The presentation will be followed by a brief conversation with ORCA staff, offering an inside look at how this innovative program reduces barriers and saves lives. Presenter & Panelists:  - Callan Fockele, MD, MS - Lupe Hurtado, Peer Counselor - Penelope Toland, RN, BSN - Aaron Billick, RN BSN, MHP Who should attend: The intended audience for this series is for anyone in Washington State involved in the care of people who use drugs and people living with substance use disorder (SUD). All disciplines are welcome and encouraged to join. Event interval: Single day event. Online Meeting Link: https://washington.zoom.us/meeting/register/uH5BfFxWTCCSCW06eehSSQ#/registration. Accessibility Contact: Meg Brunner, meganw@uw.edu. Event Types: Lectures/Seminars. Event sponsors: UW Addictions, Drug & Alcohol Institute, with funding from the State Opioid Response (SOR) grant from SAMHSA. Tuesday, February 10, 2026, 12:00 PM – 1:00 PM. Webinar - register at: https://washington.zoom.us/meeting/register/uH5BfFxWTCCSCW06eehSSQ#/registration.